pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2010-6-87-97pulmo-1723Research ArticleОБЗОРЫREVIEWРоль малых дыхательных путей при бронхиальной астмеАвдеевС. Н.serg_avdeev@list.ru201028122010068797Copyright © Авдеев С.Н., 20102010Авдеев С.Н.Авдеев С.Н.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/1723бронхиальная астмамалые дыхательные путидистальные дыхательные путиэкстрамелкодисперсные ингаля� ционные глюкокортикостероидыкомбинированные препаратыReferencesMannino D.M., Homa D.M., Akinbami L.I. et al. Surveil� lance of asthma - United States, 1980-1990. Morb. Mort. Wkly Rep. Surveill. Summ. 2002; 51: 1-13Mannino D.M., Homa D.M., Akinbami L.I. et al. Surveil� lance of asthma - United States, 1980-1990. Morb. Mort. Wkly Rep. Surveill. Summ. 2002; 51: 1-13Global initiative for asthma: Global strategy for asthma management and prevention. NHLBI / WHO Workshop Report. Updated 2009. Available at: http://www.ginasthma. comGlobal initiative for asthma: Global strategy for asthma management and prevention. NHLBI / WHO Workshop Report. Updated 2009. Available at: http://www.ginasthma. comBateman E.D., Boushey H.A., Bousquet J. et al. Can guide� line�defined asthma control be achieved? The gaining opti� mal asthma control study. Am. J. Respir. Crit. Care Med. 2004; 170: 836-844Bateman E.D., Boushey H.A., Bousquet J. et al. Can guide� line�defined asthma control be achieved? The gaining opti� mal asthma control study. Am. J. Respir. Crit. Care Med. 2004; 170: 836-844Morgan W.J., Stern D.A., Sherrill D.L. et al. Outcome of asthma and wheezing in the first 6 years of life: follow�up through adolescence. Am. J. Respir. Crit. Care Med. 2005; 172: 1253-1258Morgan W.J., Stern D.A., Sherrill D.L. et al. Outcome of asthma and wheezing in the first 6 years of life: follow�up through adolescence. Am. J. Respir. Crit. Care Med. 2005; 172: 1253-1258Van Ganse E., Laforest L., Pietri G. et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur. Respir. J. 2002; 20: 260-267Van Ganse E., Laforest L., Pietri G. et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur. Respir. J. 2002; 20: 260-267Van Ganse E., Antonicelli L., Zhang Q. et al. Asthma�related resource use and cost by GINA classification of severity in three European countries. Respir. Med. 2006; 100: 140-147Van Ganse E., Antonicelli L., Zhang Q. et al. Asthma�related resource use and cost by GINA classification of severity in three European countries. Respir. Med. 2006; 100: 140-147Burgel P.R., de Blic J., Chanez P. et al. Update on the roles of distal airways in asthma. Eur. Respir. Rev. 2009; 18: 80-95Burgel P.R., de Blic J., Chanez P. et al. Update on the roles of distal airways in asthma. Eur. Respir. Rev. 2009; 18: 80-95Hyde D.M., Hamid Q., Irvin C.G. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J. Allergy Clin. Immunol. 2009; 124: 72-77Hyde D.M., Hamid Q., Irvin C.G. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J. Allergy Clin. Immunol. 2009; 124: 72-77Contoli M., Bousquet J., Fabbri L.M. et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 65: 141-151Contoli M., Bousquet J., Fabbri L.M. et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 65: 141-151Weibel E.R. Morphometry of the human lung. New York: Academic Press; 1963Weibel E.R. Morphometry of the human lung. New York: Academic Press; 1963Wright J.L. Small airway diseases: its role in chronic airway obstruction. Semin. Respir. Med. 1992; 13: 72-84Wright J.L. Small airway diseases: its role in chronic airway obstruction. Semin. Respir. Med. 1992; 13: 72-84Garg K., Lynch D.A., Newell J.D., King T.E. Proliferative and constrictive bronchiolitis: classification and radiological features. Am. J. Roentgenol. 1994; 162: 803-808Garg K., Lynch D.A., Newell J.D., King T.E. Proliferative and constrictive bronchiolitis: classification and radiological features. Am. J. Roentgenol. 1994; 162: 803-808Macklem P.T., Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J. Appl. Physiol. 1967, 22: 395-401Macklem P.T., Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J. Appl. Physiol. 1967, 22: 395-401Macklem P.T., Mead J. Factors determining maximum expiratory flow in dogs. J. Appl. Physiol. 1968, 25: 159-169Macklem P.T., Mead J. Factors determining maximum expiratory flow in dogs. J. Appl. Physiol. 1968, 25: 159-169Van Brabandt H., Cauberghs M., Verbeken E. et al. Partitioning of pulmonary impedance in excised human and canine lungs. J. Appl. Physiol. 1983, 55: 1733-1742Van Brabandt H., Cauberghs M., Verbeken E. et al. Partitioning of pulmonary impedance in excised human and canine lungs. J. Appl. Physiol. 1983, 55: 1733-1742Wagner E.M., Liu M.C., Weinmann G.G. et al. Peripheral lung resistance in normal and asthmatic subjects. Am. Rev. Respir. Dis. 1990; 148: 584-588Wagner E.M., Liu M.C., Weinmann G.G. et al. Peripheral lung resistance in normal and asthmatic subjects. Am. Rev. Respir. Dis. 1990; 148: 584-588Wagner E.M., Bleecker E.R., Permutt S. et al. Direct assess� ment of small airways reactivity in human subjects. Am. J. Respir. Crit. Care Med. 1998; 157: 447-452Wagner E.M., Bleecker E.R., Permutt S. et al. Direct assess� ment of small airways reactivity in human subjects. Am. J. Respir. Crit. Care Med. 1998; 157: 447-452Yanai M., Sekizawa K., Ohrui T. et al. Site of airway obstruc� tion in pulmonary disease: direct measurement of intra� bronchial partition the central and peripheral airway resist� ance in a pressure. J. Appl. Physiol. 1992; 72: 1016-1023Yanai M., Sekizawa K., Ohrui T. et al. Site of airway obstruc� tion in pulmonary disease: direct measurement of intra� bronchial partition the central and peripheral airway resist� ance in a pressure. J. Appl. Physiol. 1992; 72: 1016-1023Gibson G.J. Pulmonary hyperinflation a clinical overview. Eur. Respir. J. 1996; 9: 2640-2649Gibson G.J. Pulmonary hyperinflation a clinical overview. Eur. Respir. J. 1996; 9: 2640-2649Sorkness R.L., Bleecker E.R., Busse W.W. et al. Lung func� tion in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J. Appl. Physiol. 2008; 104: 394-403Sorkness R.L., Bleecker E.R., Busse W.W. et al. Lung func� tion in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J. Appl. Physiol. 2008; 104: 394-403Wenzel S.E., Schwartz L.B., Langmack E.L. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 1999; 160: 1001-1008Wenzel S.E., Schwartz L.B., Langmack E.L. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 1999; 160: 1001-1008Marseglia G.L., Cirillo I., Vizzaccaro A. et al. Role of forced expiratory flow at 25-75 % as an early marker of small air� ways impairment in subjects with allergic rhinitis. Allergy Asthma Proc. 2007; 28: 74-78Marseglia G.L., Cirillo I., Vizzaccaro A. et al. Role of forced expiratory flow at 25-75 % as an early marker of small air� ways impairment in subjects with allergic rhinitis. Allergy Asthma Proc. 2007; 28: 74-78Hansen J.E., Sun X.G., Wasserman K. Discriminating meas� ures and normal values for expiratory obstruction. Chest 2006; 129: 369-377Hansen J.E., Sun X.G., Wasserman K. Discriminating meas� ures and normal values for expiratory obstruction. Chest 2006; 129: 369-377Pellegrino R., Viegi G., Brusasco V. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26: 948-968Pellegrino R., Viegi G., Brusasco V. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26: 948-968Bourdin A., Paganin F., Prefaut C. et al. Nitrogen washout slope in poorly controlled asthma. Allergy 2006; 61: 85-89Bourdin A., Paganin F., Prefaut C. et al. Nitrogen washout slope in poorly controlled asthma. Allergy 2006; 61: 85-89Make B., Lapp N.L. Factors influencing the measurement of closing volume. Am. Rev. Respir. Dis. 1975; 111: 749-754Make B., Lapp N.L. Factors influencing the measurement of closing volume. Am. Rev. Respir. Dis. 1975; 111: 749-754McFadden E.R., Holmes B., Kiser R. Variability of closing volume measurements in normal man. Am. Rev. Respir. Dis. 1975; 111: 135-140McFadden E.R., Holmes B., Kiser R. Variability of closing volume measurements in normal man. Am. Rev. Respir. Dis. 1975; 111: 135-140Antic R., Macklem P.T. The influence of clinical factors on the site of airway obstruction in asthma. Am. Rev. Respir. Dis. 1976; 114: 851-859Antic R., Macklem P.T. The influence of clinical factors on the site of airway obstruction in asthma. Am. Rev. Respir. Dis. 1976; 114: 851-859Berend N., Nelson A., Rutland M.B. et al. The maximum expiratory flow�volume curve with air and a low�density gas mixture. An analysis of subject and observer variability. Chest 1981; 80: 23-30Berend N., Nelson A., Rutland M.B. et al. The maximum expiratory flow�volume curve with air and a low�density gas mixture. An analysis of subject and observer variability. Chest 1981; 80: 23-30Zack R.T., Solliday N.H., Celik L. et al. Variability of the volume of isoflow. Chest 1981; 79: 269-272Zack R.T., Solliday N.H., Celik L. et al. Variability of the volume of isoflow. Chest 1981; 79: 269-272Saadeh C., Goldman M., Gaylor P. Forced oscillation using impulse oscillometry (IOS) detects false negative spirometry in symptomatic patients with reactive airways. J. Allergy Clin. Immun. 2003; 111: 136Saadeh C., Goldman M., Gaylor P. Forced oscillation using impulse oscillometry (IOS) detects false negative spirometry in symptomatic patients with reactive airways. J. Allergy Clin. Immun. 2003; 111: 136Landser F.J., Clement J., Van de Woestijne K.P. Normal val� ues of total respiratory resistance and reactance determined by forced oscillations: influence of smoking. Chest 1982; 81: 586-591Landser F.J., Clement J., Van de Woestijne K.P. Normal val� ues of total respiratory resistance and reactance determined by forced oscillations: influence of smoking. Chest 1982; 81: 586-591Mahut B., Delacourt C., ZerahLancner F. et al. Increase in alveolar nitric oxide in the presence of symptoms in child� hood asthma. Chest 2004; 125: 1012-1018Mahut B., Delacourt C., ZerahLancner F. et al. Increase in alveolar nitric oxide in the presence of symptoms in child� hood asthma. Chest 2004; 125: 1012-1018Battaglia S., den Hertog H., Timmers M.C. et al. Small air� ways function and molecular markers in exhaled air in mild asthma. Thorax 2005; 60: 639-644Battaglia S., den Hertog H., Timmers M.C. et al. Small air� ways function and molecular markers in exhaled air in mild asthma. Thorax 2005; 60: 639-644King G.G., Muller N.L., Par P.D. Evaluation of airways in obstructive pulmonary disease using high�resolution com� puted tomography. Am. J. Respir. Crit. Care Med. 1999; 159: 992-1004King G.G., Muller N.L., Par P.D. Evaluation of airways in obstructive pulmonary disease using high�resolution com� puted tomography. Am. J. Respir. Crit. Care Med. 1999; 159: 992-1004Lynch D.A., Newell J.D., Tschomper B.A. et al. Uncompli� cated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993; 188: 829-833Lynch D.A., Newell J.D., Tschomper B.A. et al. Uncompli� cated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993; 188: 829-833Park J.W., Hong Y.K., Kim C.W. et al. High�resolution com� puted tomography in patients with bronchial asthma: corre� lation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J. Investig. Allergol. Clin. Immunol. 1997; 7: 186-192Park J.W., Hong Y.K., Kim C.W. et al. High�resolution com� puted tomography in patients with bronchial asthma: corre� lation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J. Investig. Allergol. Clin. Immunol. 1997; 7: 186-192McNittGray M.F., Goldin J.G., Johnson T.D. et al. Development and testing of image�processing methods for the quantitative assessment of airway hyperresponsiveness from high�resolution CT images. J. Comput. Assist. Tomogr. 1997; 21: 939-947McNittGray M.F., Goldin J.G., Johnson T.D. et al. Development and testing of image�processing methods for the quantitative assessment of airway hyperresponsiveness from high�resolution CT images. J. Comput. Assist. Tomogr. 1997; 21: 939-947Goldin J.G., McNittGray M.F., Sorenson S.M. et al. Airway hyperreactivity assessment with helical thin�section C. Radiology 1998; 208: 321-329Goldin J.G., McNittGray M.F., Sorenson S.M. et al. Airway hyperreactivity assessment with helical thin�section C. Radiology 1998; 208: 321-329Goldin J.G., McNittGray M.F. Johnson T. et al. Functional helical high�resolution CT: sensitive test for detecting air trapping due to reversible airway hyperreactivity. Radiology 1995; 197 (P): 437Goldin J.G., McNittGray M.F. Johnson T. et al. Functional helical high�resolution CT: sensitive test for detecting air trapping due to reversible airway hyperreactivity. Radiology 1995; 197 (P): 437Laurent F., Latrabe V., Raherison C. et al. Functional signif� icance of air trapping detected in moderate asthma. Eur. Radiol. 2000; 10: 1404-1410Laurent F., Latrabe V., Raherison C. et al. Functional signif� icance of air trapping detected in moderate asthma. Eur. Radiol. 2000; 10: 1404-1410Jensen S.P., Lynch D.A., Brown K.K. et al. High�resolution CT features of severe asthma and bronchiolitis obliterans. Clin. Radiol. 2002; 57: 1078-1085Jensen S.P., Lynch D.A., Brown K.K. et al. High�resolution CT features of severe asthma and bronchiolitis obliterans. Clin. Radiol. 2002; 57: 1078-1085Ueda T., Niimi A., Matsumoto H. et al. Role of small airways in asthma: investigation using high�resolution computed tomog� raphy. J. Allergy Clin. Immunol. 2006; 118: 1019-1025Ueda T., Niimi A., Matsumoto H. et al. Role of small airways in asthma: investigation using high�resolution computed tomog� raphy. J. Allergy Clin. Immunol. 2006; 118: 1019-1025Jain N., Covar R.A., Gleason M.C. et al. Quantitative com� puted tomography detects peripheral airway disease in asth� matic children. Pediatr. Pulmonol. 2005; 40: 211-218Jain N., Covar R.A., Gleason M.C. et al. Quantitative com� puted tomography detects peripheral airway disease in asth� matic children. Pediatr. Pulmonol. 2005; 40: 211-218Lee Y.M., Park J.S., Hwang J.H. et al. High�resolution CT findings in patients with near�fatal asthma: comparison of patients with mild�to�severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004; 126: 1840-1848Lee Y.M., Park J.S., Hwang J.H. et al. High�resolution CT findings in patients with near�fatal asthma: comparison of patients with mild�to�severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004; 126: 1840-1848Goldin J.G.,Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267Goldin J.G.,Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267Yablonskiy D.A., Sukstanskii A.L., Leawoods J.C. et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc. Natl. Acad. Sci. USA 2002; 99: 3111-3116Yablonskiy D.A., Sukstanskii A.L., Leawoods J.C. et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc. Natl. Acad. Sci. USA 2002; 99: 3111-3116Samee S., Altes T., Powers P. et al. Imaging the lungs in asth� matic patients by using hyperpolarized helium�3 magnetic resonance: assessment of response to methacholine and exercise challenge. J. Allergy Clin. Immunol. 2003; 111: 1205-1211Samee S., Altes T., Powers P. et al. Imaging the lungs in asth� matic patients by using hyperpolarized helium�3 magnetic resonance: assessment of response to methacholine and exercise challenge. J. Allergy Clin. Immunol. 2003; 111: 1205-1211Kauczor H.U., Chen X.J., van Beek E.J., Schreiber W.G. Pulmonary ventilation imaged bymagnetic resonance: at the doorstep of clinical application. Eur. Respir. J. 2001; 17: 1008-1023Kauczor H.U., Chen X.J., van Beek E.J., Schreiber W.G. Pulmonary ventilation imaged bymagnetic resonance: at the doorstep of clinical application. Eur. Respir. J. 2001; 17: 1008-1023de Lange E.E., Altes T.A., Patrie J.T. et al. Evaluation of asthma with hyperpolarized helium�3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130: 1055-1062de Lange E.E., Altes T.A., Patrie J.T. et al. Evaluation of asthma with hyperpolarized helium�3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130: 1055-1062Holz O., Jorres R.A., Magnussen H. Monitoring central and peripheral airway inflammation in asthma. Respir. Med. 2000; 94 (Suppl. D): 7-12Holz O., Jorres R.A., Magnussen H. Monitoring central and peripheral airway inflammation in asthma. Respir. Med. 2000; 94 (Suppl. D): 7-12Huber H.L., Koessle K. The pathology of bronchial asthma. Arch. Intern. Med. 1922; 30: 689-760Huber H.L., Koessle K. The pathology of bronchial asthma. Arch. Intern. Med. 1922; 30: 689-760Saetta M., DeStefano A., Rosina C. et al. Quantitative struc� tural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 1991; 143: 138-143Saetta M., DeStefano A., Rosina C. et al. Quantitative struc� tural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 1991; 143: 138-143Kuwano K., Bosken C.H., Pare P.D. et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1993; 148: 1220-1225Kuwano K., Bosken C.H., Pare P.D. et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1993; 148: 1220-1225Haley K.J., Sunday M.E., Wiggs B.R. et al. Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 1998; 158: 565-572Haley K.J., Sunday M.E., Wiggs B.R. et al. Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 1998; 158: 565-572de Magalhäes Simöes S., dos Santos M.A. et al. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clin. Exp. Allergy 2005; 35: 602-611de Magalhäes Simöes S., dos Santos M.A. et al. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clin. Exp. Allergy 2005; 35: 602-611de Medeiros Matsushita M., da Silva L.F., dos Santos M.A. et al. Airway proteoglycans are differentially altered in fatal asth� ma. J. Pathol. 2005; 207: 102-110de Medeiros Matsushita M., da Silva L.F., dos Santos M.A. et al. Airway proteoglycans are differentially altered in fatal asth� ma. J. Pathol. 2005; 207: 102-110Dolhnikoff M., da Silva L.F., de Araujo B.B. et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 2009; 123: 1090-1097Dolhnikoff M., da Silva L.F., de Araujo B.B. et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 2009; 123: 1090-1097Mauad T., Silva L.F., Santos M.A. et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 2004; 170: 857-862Mauad T., Silva L.F., Santos M.A. et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 2004; 170: 857-862Shiang C., Mauad T., Senhorini A. et al. Pulmonary periar� terial inflammation in fatal asthma. Clin. Exp. Allergy 2009; 39: 1499-1507Shiang C., Mauad T., Senhorini A. et al. Pulmonary periar� terial inflammation in fatal asthma. Clin. Exp. Allergy 2009; 39: 1499-1507Hamid Q., Song Y., Kotsimbos T.C. et al. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 1997; 100: 44-51Hamid Q., Song Y., Kotsimbos T.C. et al. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 1997; 100: 44-51Hamid Q. Peripheral inflammation is more important than central inflammation. Respir. Med. 1997: 91 (Suppl. A): 11-12Hamid Q. Peripheral inflammation is more important than central inflammation. Respir. Med. 1997: 91 (Suppl. A): 11-12Kraft M., Djukanovic R., Wilson S. et al. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 1505-1510Kraft M., Djukanovic R., Wilson S. et al. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 1505-1510McFadden E.R., Kiser R., DeGroot W.J. Acute bronchial asthma. Relations between clinical and physiologic meas� ures. N. Engl. J. Med. 1973; 288: 221-225McFadden E.R., Kiser R., DeGroot W.J. Acute bronchial asthma. Relations between clinical and physiologic meas� ures. N. Engl. J. Med. 1973; 288: 221-225Kraft M., Pak J., Martin R.J. et al. Distal lung dysfunction at night in nocturnal asthma. Am. J. Respir. Crit. Care Med. 2001; 163: 1551-1556Kraft M., Pak J., Martin R.J. et al. Distal lung dysfunction at night in nocturnal asthma. Am. J. Respir. Crit. Care Med. 2001; 163: 1551-1556Lange P., Parner J., Vestbo J. et al. A 15�year follow�up study of ventilatory function in adults with asthma. N. Engl. J. Med. 1998; 339: 1194-1200Lange P., Parner J., Vestbo J. et al. A 15�year follow�up study of ventilatory function in adults with asthma. N. Engl. J. Med. 1998; 339: 1194-1200Peat J.K., Woolcock A.J., Culle K. Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 1987; 70: 171-179Peat J.K., Woolcock A.J., Culle K. Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 1987; 70: 171-179in't Veen J.C., Beekman A.J., Bel E.H. et al. Recurrent exac� erbations in severe asthma are associated with enhanced air� way closure during stable episodes. Am. J. Respir. Crit. Care Med. 2000; 161: 1902-1906in't Veen J.C., Beekman A.J., Bel E.H. et al. Recurrent exac� erbations in severe asthma are associated with enhanced air� way closure during stable episodes. Am. J. Respir. Crit. Care Med. 2000; 161: 1902-1906van Veen I.H., Sterk P.J., Schot R. et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur. Respir. J. 2006; 27: 951-956van Veen I.H., Sterk P.J., Schot R. et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur. Respir. J. 2006; 27: 951-956Leach C.L. Improved delivery of inhaled steroids to the large and small airways. Respir. Med. 1998; 92 (Suppl. A): 3-8Leach C.L. Improved delivery of inhaled steroids to the large and small airways. Respir. Med. 1998; 92 (Suppl. A): 3-8Lipworth B.J. Targets for inhaled drugs. Respir. Med. 2000; 94 (Suppl. D): S13-S16Lipworth B.J. Targets for inhaled drugs. Respir. Med. 2000; 94 (Suppl. D): S13-S16Worth H., Muir J.F., Pieters W.R. Comparison of hydroflu� oroalkane�beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration 2001; 68: 517-526Worth H., Muir J.F., Pieters W.R. Comparison of hydroflu� oroalkane�beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration 2001; 68: 517-526Reichel W., Dahl R., Ringdal N. et al. Extrafine beclometha� sone dipropionate breath�actuated inhaler (400 micrograms / day) versus budesonide dry powder inhaler (800 micrograms / day) in asthma. Int. J. Clin. Pract. 2001; 55: 100-106Reichel W., Dahl R., Ringdal N. et al. Extrafine beclometha� sone dipropionate breath�actuated inhaler (400 micrograms / day) versus budesonide dry powder inhaler (800 micrograms / day) in asthma. Int. J. Clin. Pract. 2001; 55: 100-106Ederle K. Multicentre Study Group. Improved control of asthma symptoms with a reduced dose of HFA�BDP extrafine aerosol: an open�label, randomised study. Eur. Rev. Med. Pharmacol. Sci. 2003; 7: 45-55Ederle K. Multicentre Study Group. Improved control of asthma symptoms with a reduced dose of HFA�BDP extrafine aerosol: an open�label, randomised study. Eur. Rev. Med. Pharmacol. Sci. 2003; 7: 45-55Davies R.J., Stampone P., O'Connor B.J. Hydrofluoro� alkane�134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir. Med. 1998; 92 (Suppl. A): 23-31Davies R.J., Stampone P., O'Connor B.J. Hydrofluoro� alkane�134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir. Med. 1998; 92 (Suppl. A): 23-31Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000; 37: 389-398Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000; 37: 389-398Fowler S.J., Currie G.P., Lipworth B.J. Step�down therapy with low�dose fluticasone�salmeterol combination or medi� um�dose hydrofluoroalkane 134a�beclomethasone alone. J. Allergy Clin. Immunol. 2002; 109: 929-935Fowler S.J., Currie G.P., Lipworth B.J. Step�down therapy with low�dose fluticasone�salmeterol combination or medi� um�dose hydrofluoroalkane 134a�beclomethasone alone. J. Allergy Clin. Immunol. 2002; 109: 929-935Molimard M., Martinat Y., Rogeaux Y. et al. Improvement of asthma control with beclomethasone extrafine aerosol com� pared to fluticasone and budesonide. Respir. Med. 2005; 99: 770-778Molimard M., Martinat Y., Rogeaux Y. et al. Improvement of asthma control with beclomethasone extrafine aerosol com� pared to fluticasone and budesonide. Respir. Med. 2005; 99: 770-778Busse W.W., Brazinsky S., Jacobson K. et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is propor� tional to dose and is improved by formulation with a new pro� pellant. J. Allergy Clin. Immunol. 1999; 104: 1215-1222Busse W.W., Brazinsky S., Jacobson K. et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is propor� tional to dose and is improved by formulation with a new pro� pellant. J. Allergy Clin. Immunol. 1999; 104: 1215-1222Goldin J.G., Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267Goldin J.G., Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000: 37 (5): 389-398Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000: 37 (5): 389-398Ohbayashi H. One�year evaluation of the preventative effect of hydrofluoroalkane�beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007: 74: 146-153Ohbayashi H. One�year evaluation of the preventative effect of hydrofluoroalkane�beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007: 74: 146-153Dhillon S., Keating G.M. Beclometasone dipropionate / for� motherol. In an HFA�propelled pressurized metered�dose inhaler. Drugs 2006; 66: 1475-1483Dhillon S., Keating G.M. Beclometasone dipropionate / for� motherol. In an HFA�propelled pressurized metered�dose inhaler. Drugs 2006; 66: 1475-1483Bousquet J., Poli G., Acerbi D. et al. Systemic exposure and implications for lung deposition with extra�fine HFA beclometasone dipropionat / formoterol fixed combination. Clin. Pharmacokinet. 2009; 48: 347-358Bousquet J., Poli G., Acerbi D. et al. Systemic exposure and implications for lung deposition with extra�fine HFA beclometasone dipropionat / formoterol fixed combination. Clin. Pharmacokinet. 2009; 48: 347-358De Backer W., Devolder A., Poli G. et al. Lung deposition of BDP / formoterol HFA pMDI in healthy volunteers, asth� matic, and COPD patients. J. Aerosol Med. Pulm. Drug Deliv. 2010; 23: 137-148De Backer W., Devolder A., Poli G. et al. Lung deposition of BDP / formoterol HFA pMDI in healthy volunteers, asth� matic, and COPD patients. J. Aerosol Med. Pulm. Drug Deliv. 2010; 23: 137-148BonnetGonod F., Kottakis I., Ballabio M. et al. Superior efficacy of a low daily dose of a new fixed combination of beclometasone dipropionate / formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study. 16th Annual Congress of the European Respiratory Society; 2006 Sep. 2-6; Munich: P1237BonnetGonod F., Kottakis I., Ballabio M. et al. Superior efficacy of a low daily dose of a new fixed combination of beclometasone dipropionate / formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study. 16th Annual Congress of the European Respiratory Society; 2006 Sep. 2-6; Munich: P1237Huchon G., Magnussen H., Chuchalin A. et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir. Med. 2009; 103: 41-49Huchon G., Magnussen H., Chuchalin A. et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir. Med. 2009; 103: 41-49Scichilone N., Battaglia S., Sorino C. et al. Effects of extra� fine inhaled beclomethasone / formoterol on both large and small airways in asthma. Allergy 2010; 65: 897-902Scichilone N., Battaglia S., Sorino C. et al. Effects of extra� fine inhaled beclomethasone / formoterol on both large and small airways in asthma. Allergy 2010; 65: 897-902Papi A., Paggiaro P., Nicolini G. et al. Beclomethasone / for� moterol vs fluticasone / salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62: 1182-1188Papi A., Paggiaro P., Nicolini G. et al. Beclomethasone / for� moterol vs fluticasone / salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62: 1182-1188Papi A., Paggiaro P.L., Nicolini G. et al. Beclomethasone / formoterol versus budesonide / formoterol combination therapy in asthma. Eur. Respir. J. 2007; 29: 682-689Papi A., Paggiaro P.L., Nicolini G. et al. Beclomethasone / formoterol versus budesonide / formoterol combination therapy in asthma. Eur. Respir. J. 2007; 29: 682-689
The authors declare that there are no conflicts of interest present.